Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
1987
-
Total 13F shares, excl. options
-
1.31B
-
Shares change
-
+39.2M
-
Total reported value, excl. options
-
$110B
-
Value change
-
+$3.31B
-
Put/Call ratio
-
0.61
-
Number of buys
-
813
-
Number of sells
-
-918
-
Price
-
$84.10
Significant Holders of ABBOTT LABORATORIES - COM (ABT) as of Q2 2019
2,132 filings reported holding ABT - ABBOTT LABORATORIES - COM as of Q2 2019.
ABBOTT LABORATORIES - COM (ABT) has 1,987 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.31B shares
.
Largest 10 shareholders include VANGUARD GROUP INC (148M shares), BlackRock Inc. (127M shares), Capital Research Global Investors (117M shares), STATE STREET CORP (73.4M shares), WELLINGTON MANAGEMENT GROUP LLP (44.3M shares), Capital International Investors (38.1M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (32.2M shares), NORTHERN TRUST CORP (26.5M shares), FMR LLC (25M shares), and GEODE CAPITAL MANAGEMENT, LLC (24.1M shares).
This table shows the top 1987 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.